4 insiders reported 11 Form 4 transactions for Apimeds Pharmaceuticals US, Inc. (APUS) over the past 18 months (most recent 2025-06-11). Recent activity: Inscobee Inc. (Insider) Buy 71,090 shares, Inscobee Inc. (Insider) Buy 44,041 shares, Emerson Erik C. (Chief Executive Officer) Buy 750,000 shares, Kim Christopher (Chairman and CMO) Buy 250,000 shares, Kim Christopher (Chairman and CMO) Buy 19,770 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-06-11 | Inscobee Inc. | Insider | Buy | 71,090 | $184,834 |
| 2025-06-11 | Inscobee Inc. | Insider | Buy | 44,041 | $114,507 |
| 2025-05-20 | Emerson Erik C. | Chief Executive Officer | Buy | 750,000 | $0 |
| 2025-05-20 | Kim Christopher | Chairman and CMO | Buy | 250,000 | $0 |
| 2025-05-15 | Kim Christopher | Chairman and CMO | Buy | 19,770 | $0 |
| 2025-05-15 | Kim Christopher | Chairman and CMO | Buy | 7,730 | $0 |
| 2025-05-14 | Inscobee Inc. | Insider | Buy | 500,000 | $2.0M |
| 2025-05-14 | Inscobee Inc. | Insider | Buy | 182,002 | $473,205 |
| 2025-05-14 | Inscobee Inc. | Insider | Buy | 71,090 | $184,834 |
| 2025-05-14 | Inscobee Inc. | Insider | Buy | 44,041 | $114,507 |
| 2025-05-14 | Koo Jakap | Director | Buy | 28,500 | $0 |
Source: SEC Form 4 filings · as of 2025-06-11